Phase 3 trial Archives | ADHD Core

Prescription bottle labeled Centanafadine beside an FDA review sign and a July 2026 calendar with July 24 circled, representing the FDA review timeline for the investigational ADHD medication.

News

Centanafadine for ADHD: FDA Review Update, Decision Pending

April 19, 2026April 19, 2026

Centanafadine for ADHD: FDA Review Timeline, Phase 3 Data and What It Could Mean ADHD treatment · drug development · FDA review A new class… Continue Reading Centanafadine for ADHD: FDA Review Update, Decision Pending

Exit mobile version